CNSY — Cerenome, Inc.
CNSY dilution and offerings
- Dilution risk: High
- Float: 167.2M shares
🔔 Alert me if CNSY files an offering or S-3
$1.71+0.59%
Last close: · regular session
Last 59 sessions
Dilution risk: high. Float: 167.2M shares. Latest SEC filing: 8-K on Oct 2, 2026. CNSY closed at $1.71 (+0.59%) on Nov 2, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for CNSY in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Pharmaceuticals
- Country: US
- Exchange: NASDAQ
- Employees: 28
- Website: https://www.cerenome.com
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Latest SEC filings for CNSY
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.